Insiders Updates
Analysts review Regeneron Pharmaceuticals, Inc.’s rating
Regeneron Pharmaceuticals, Inc.’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.22 million on
Menu
Regeneron Pharmaceuticals, Inc.’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.22 million on
Regeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on Apr
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Regeneron Pharmaceuticals, Inc.’s recent filing unveils that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on
Regeneron Pharmaceuticals, Inc.’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on
Regeneron Pharmaceuticals, Inc.’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) does about 630.37K shares in volume on a normal day but saw 492717 shares change hands